Dr. Tim Ridgway
Brief: USD vaccination event switches to Moderna after Johnson & Johnson FDA approval paused
A vaccination event on the USD campus substituted Moderna’s first dose for Johnson & Johnson’s single-dose vaccination after the FDA announced a temporary pause on Johnson & Johnson’s approval. Both the CDC and FDA are investigating blood clots developed by six women after vaccination. 6.8 million doses of the Johnson & Johnson vaccine have been […]
1 min read